慢性创伤性脑病的研究空白与争议:综述
本综述讨论慢性创伤性脑病(CTE)的流行病学、机制与临床病理关联的研究现状。CTE 病理诊断标准已建立,但临床综合征定义及体内生物标志物仍缺失,症状归因受多种病前与共病因素影响。现有数据虽有限且存在选择偏倚,但提示重复性脑外伤是 CTE 病理特征的最大风险因素。
要点
- CTE 病理诊断标准已建立,但临床综合征定义和诊断所需症状仍不明确。
- 缺乏经验证的 CTE 病理特征体内生物标志物及纵向神经心理评估。
- 重复性脑外伤是 CTE 病理特征的最大风险因素,但临床病理关联和症状进展 largely 未知。
核心结论
- 现有数据虽有限且受选择偏倚影响,但表明重复性脑外伤是 CTE 病理特征的最大风险因素。
- CTE 的临床病理关联及症状起病与进展性质 largely 未知。
- 考虑认知储备对解读 CTE 相关认知结局和制定预防性治疗方案可能至关重要。
研究设计与样本
- 本文为综述,讨论 CTE 的科学现状并提出研究及解读高危人群认知变化的考量。
- 当前对 CTE 流行病学因素、机制和临床病理关联的理解依赖于死后病例系列研究。
主要发现
- 近期制定的 CTE 病理诊断标准是区分 CTE 与其他神经退行性疾病的重要一步。
- 定义与 CTE 相关的临床综合征及诊断所需必要和充分症状的工作滞后。
- 缺乏经验证的 CTE 病理特征体内生物标志物及纵向神经心理评估追踪仍是重大障碍。
- 退役运动员候选症状归因于 CTE 受多种影响认知储备的病前和共病因素干扰。
临床怎么用
- 在解读高危人群认知变化时需考虑认知储备及多种病前和共病因素。
- CTE 研究应借鉴其他神经退行性疾病领域已建立的原则和临床病理考量的细微差别。
局限性
- 现有数据有限且受选择偏倚影响。
- CTE 的临床病理关联及症状起病与进展性质 largely 未知。
- 缺乏经验证的体内生物标志物和纵向神经心理评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Scientific and lay interest in negative outcomes associated with exposure to repetitive brain trauma (RBT) continues to strengthen. Concerns about the association between RBT and dementia began more than a century ago, but have resurfaced in the last decade with the more recently described chronic traumatic encephalopathy (CTE). Chronic traumatic encephalopathy is a tauopathy associated with RBT that has become inextricably linked to conversations about sport-related concussion and mild traumatic brain injury. Accordingly, specific populations such as collision sport athletes and certain military personnel are of particular interest owing to their unique exposure to RBT. The gaps and controversies in our understanding of the epidemiologic factors, mechanism, and clinicopathological correlates of CTE reflect the current reliance on postmortem case series investigations. This review discusses the state of the science of CTE and raises considerations for researching and interpreting cognitive changes in members of at-risk populations. OBSERVATIONS: The recent development of pathological diagnostic criteria for CTE represented an important step for differentiating CTE from other neurodegenerative diseases. By comparison, defining the clinical syndrome(s) associated with CTE and the necessary and sufficient symptoms needed for its diagnosis lags behind. The absence of validated in vivo biomarkers of pathological characteristics of CTE and longitudinal tracking with neuropsychological evaluation remains a significant hurdle. Attribution of candidate symptoms in retired athletes to CTE is complicated by the presence of multiple premorbid and comorbid factors affecting cognitive reserve that influence normal or expected cognitive functioning. This is a critical issue in appropriately defining reference groups for normative comparisons. CONCLUSIONS AND RELEVANCE: Available data, while limited and complicated by selection bias, indicate that exposure to RBT represents the greatest risk factor for CTE pathological features, although clinicopathological correlates and the nature of onset and progression of symptoms are largely unknown. Considering aspects of cognitive reserve is likely essential for both interpreting cognitive outcomes associated with CTE and for developing preventive treatment programs. Research on CTE would benefit greatly from incorporating principles established within other areas of neurodegenerative disease and the nuances of clinicopathological considerations.
引用
- Asken BM, Sullan MJ, DeKosky ST, et al. Research Gaps and Controversies in Chronic Traumatic Encephalopathy: A Review. JAMA Neurol. 2017. PMID: 28975240. doi:10.1001/jamaneurol.2017.2396
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。